In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern

Asian Pacific Journal of Tropical Medicine

Volumn 5, Issue 3, 2012, Pages 210-213

  Ponnusamy, Poovendran ^a   Natarajan, Vidhya ^a   Sevanan, Murugan ^b  

^a DR N G P ARTS AND SCIENCE COLLEGE   (India)

^b KARUNYA UNIVERSITY   (India)

Author keywords

Biofilm; Escherichia coli; Multi drug resistance; Urinary tract infection

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TOBRAMYCIN;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; BIOFILM; CONTROLLED STUDY; DISK DIFFUSION; GRAM STAINING; HUMAN; IN VITRO STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; URINALYSIS; UROPATHOGENIC ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84856503533     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(12)60026-1     Document Type: Article

References (35)

1. Anderson GG, Martin SM, Hultgren SJ Host subversion by formation of intercellular bacterial communities in the urinary tract. Microbes Infection 2004, 6(12):1094-1101.
2. Schito GC Why fosfomycin trometamol as first line therapy for uncomplicated UTI?. Int J Antimicrob Agents 2003, 22(Suppl. 2):79-83.
3. Rodriguez-Bano J, Navarro MD, Romero L, Romero L, Muniain MA, Perea EJ, et al. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 2006, 42:37-45.
4. Foxman B Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003, 49:53-70.
5. Mulvey MA, Joel DS, Juan JM, Scott JH Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U.S.A. 2000, 97:8829-8835.
6. Bower JM, Danelle SE, Matthew AM Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic 2005, 6:18-31.
7. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ Intracellular bacterial biofilm like pods in urinary tract infections. Science 2003, 301:105-107.
8. Spoering AM, Lewis K Biofilm and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 2001, 183:6746-6751.
9. Costerton JW, Cheng KJ, Geesey GG Bacterial biofilms in nature and disease. Ann Rev Microbiol 1987, 41:435-464.
10. Ishida H, Ishida Y, Yuichi K, Otani T, Sato K, Kobayashi H In vitro and in vivo activities of levofloxacin against biofilmproducing Pseudomonas aeruginosa. Antimicrob Agents Chemother 1998, 42:1641-1645.
11. Bagge N, Ciofu O, Skovgaard LT, Hoiby N Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm-growing Pseudomonas aeruginosa due to chromosomal h-lactamase. APMIS 2000, 108:589-600.
12. Mackie and McCartney practical medical microbiology 1996, Churchill Livingstone, New York. 14th ed. J.G. Collee, A.G. Fraser, B.P. Marmion, A. Simmons (Eds.).
13. Christensen GD, Simpson WA, Younger JA, Baddour LM, Barrett FF, Melton DM Adherence of cogulase negative Staphylococi to plastic tissue cultures:a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985, 22:996-1006.
14. Christensen GD, Simpson WA, Bisno AL, Beachey EH Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun 1982, 37:318-326.
15. Freeman DJ, Falkiner FR, Keane CT New method for detecting slime production by coagulase negative staphylococci. J Clin Pathol 1989, 42:872-874.
16. Clinical and Laboratory Standards Institute M100-S15. Performance standards for antimicrobial susceptibility testing, approved standard 2006, CLSI, Wayne.
17. Jones RN, Kugler KC, Pfaller MA, Winokur PL Characterization of pathogens causing urinary tract infections in hospitals in the North American: survelliance program. J Diag Microbial Infect Dis 1999, 35:55-63.
18. Soto SM, Smithson A, Martinez JA, Horcajada JP, Mensa J, Vila J Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulance factors and antimicrobial resistance. J Urol 2007, 177(1):365-368.
19. Suman E, Jose J, Varghese S, Kotian MS Study of biofilm production in Escherichia coli causing Urinary tract infection. Indian J Med Microbiol 2007, 25(3):305-306.
20. Gupta KA, Hooton D, Wobe CL, Stamm WE The prevalence of antimicrobial resistance among uropathogens causing uncomplicated cystitis in young women. Int J Antimicrob Agent 1999, 11:305-308.
21. Tenke P, Kovacs B, Jackel M, Nagy E The role of biofilm infection in urology. World J Urol 2006, 24(1):13-20.
22. Graham JC, Galloway A ACP best practice No 167: The laboratory diagnosis of urinary tract infection. J Clin Pathol 2001, 54:911-919.
23. Reisner A, Krogfelt KA, Klein BM, Zechner EL, Molin S In vivo biofilm formation of commensal and pathogenic Escherichia coli strains: impact of environmental and genetic factors. J Bacteriol 2006, 188:3572-3581.
24. Ong CLY, Ulett GC, Mabbett AN, Beaston SA, Webb RI, Monaghan W, et al. Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation. J Bacteriol 2008, 190:1054-1063.
25. Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo JM, Schembri MA Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long term persistence in the urinary tract. Infect Immun 2007, 75:3233-3244.
26. Ulett GC, Mabbett AN, Fung KC, Webb RI, Schembri MA The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formation. Microbiology 2007, 151:2321-2331.
27. Jefferson KK What drives bacteria to produce a biofilm?. FEMS Microbiol Lett 2004, 236:163-173.
28. Ophori EA, Isibor C, Onemu SO, Johnny EJ Immunological response to Helicobacter pylori among healthy volunteers in Agbor, Nigeria. Asian Pac J Trop Dis 2011, 1(1):38-40.
29. Kumar DT, Pankaja SS, Rao HK, Kate V Evaluation of Helicobacter pylori infection and other risk factors in patients with benign peptic ulcer disease. Asian Pac J Trop Dis 2011, 1(1):50-51.
30. Owolabi RS, Daniel O, Araoye MO, Osagbemi GK, Odeigah L, Ogundiran A Self-reported reasons for seeking HIV testing by people living with HIV/AIDS(PLWHA) in a tertiary hospital in Nigeria. Asian Pac J Trop Dis 2011, 1(1):59-62.
31. Wilma DSC, Kavya N, Kulkarni S Evaluation of insulin sensitivity status in polycystic ovarian syndrome. Asian Pac J Trop Dis 2011, 1(1):67-70.
32. Karki S, Kumar K Study on the possible use of Vi polysaccharide typhoid fever vaccine to control endemic typhoid fever in Nepal. Asian Pac J Trop Dis 2011, 1(1):76-79.
33. Mirnejad R, Jeddi F, Kiani J, Khoobdel M Etiology of spontaneous bacterial peritonitis and determination of their antibiotic susceptibility patterns in Iran. Asian Pac J Trop Dis 2011, 1(2):116-118.
34. Sauer K, Rickard AH, Davies DG Biofilm and biocomplexity. Microbe 2007, 7:347-353.
35. Hooton TM, Stamm WE Diagnosis and treatment of uncomplicated urinary tract infection. J Inf Dis Clinics of North America 1997, 11:551-581.